Is COVID-19 infecting wild animals? We're testing species from bats to seals to find out

COVID-19 has been found in pets, zoo animals and in a wild mink in Utah. Monitoring wildlife for COVID-19 is important for animals and humans, both of whom face risks from a jumping virus.

Kaitlin Sawatzki, Postdoctoral Infectious Disease Researcher, Tufts University • conversation
yesterday ~8 min

covid-19 coronavirus pets animals transmission sars-cov-2 viruses wildlife tigers gorillas utah mink

How anti-vax memes replicate through satire and irony

Memes that promote harmful conspiracies and memes that mock them are sometimes hard to distinguish.

Jan Buts, Postdoctoral Research Fellow, Translation Studies, Trinity College Dublin • conversation
Jan. 18, 2021 ~8 min

covid-19 coronavirus anti-vaccination anti-vaxxers memes viral-content 4chan irony

What you need to know about the new COVID-19 variants

A biologist who studies the evolution of diseases explains what's different about the two new virus strains that have been found recently, and what that means for vaccine effectiveness.

David Kennedy, Assistant Professor of Biology, Penn State • conversation
Jan. 15, 2021 ~7 min

evolution covid-19 coronavirus vaccines mutation

The simple reason West Virginia leads the nation in vaccinating nursing home residents

West Virginia turned to its local pharmacies for help. Its program's success holds some important lessons for other states and the rest of the vaccine rollout.

Tinglong Dai, Associate Professor of Operations Management & Business Analytics, Johns Hopkins Carey Business School, Johns Hopkins University School of Nursing • conversation
Jan. 14, 2021 ~6 min

covid-19 coronavirus statistics health-care sars-cov-2 pharmacy pandmics us-health-care

Americans have unrealistic expectations for a COVID-19 vaccine

Two in five Americans say they don't want a COVID-19 vaccine, which is a problem. Finding out what Americans do want from a vaccine might help.

Matt Motta, Assistant Professor of Political Science, Oklahoma State University • conversation
Jan. 13, 2021 ~9 min

covid-19 coronavirus vaccines herd-immunity covid-19-vaccine vaccine-safety vaccine-hesitancy moderna-vaccine pfizer-vaccine

Delaying second COVID-19 vaccine doses will make supplies last longer but comes with risks

With vaccine shortages looming, experts are debating whether it is important to receive two doses or whether it's better to give one dose to more people and give a second when the supply is better.

Sanjay Mishra, Project Coordinator & Staff Scientist, Vanderbilt University Medical Center, Vanderbilt University • conversation
Jan. 11, 2021 ~11 min

 covid-19  coronavirus  immune-system  pandemic  t-cells  antibodies  sars-cov-2  moderna  astrazeneca  pfizerbiontech-vaccine

Vaccine delays reveal unexpected weak link in supply chains: A shortage of workers

The shipment of goods to suppliers has become technologically sophisticated. Delays in getting out the COVID-19 vaccine to people show that the breakdowns come down to something more basic.

Anna Nagurney, John F. Smith Memorial Professor of Operations Management, University of Massachusetts Amherst • conversation
Jan. 8, 2021 ~10 min

covid-19 coronavirus covid-19-vaccines moderna-vaccine pfizer-vaccine vaccine-distribution

COVID-19 crisis in Los Angeles: Why activating 'crisis standards of care' is crucial for overwhelmed hospitals

States and hospitals are starting to declare 'crisis standards of care' as the pandemic floods their ERs. The orders have consequences – both good and bad, as a medical ethicist explains.

Maria Howard, Assistant Professor of Philosophy, Gonzaga University • conversation
Jan. 6, 2021 ~8 min

health public-health covid-19 coronavirus ethics pandemic disaster crisis california los-angeles medical-ethics

How many people need to get a COVID-19 vaccine in order to stop the coronavirus?

Researchers say around 70% of the US needs to get the coronavirus vaccine to stop the pandemic. But questions around the vaccines and regional differences add some uncertainty to that estimate.

Pedro Mendes, Professor of Cell Biology, University of Connecticut • conversation
Jan. 5, 2021 ~8 min

covid-19 coronavirus transmission vaccines immunity population herd-immunity viruses pfizer moderna astrazeneca

The cold supply chain can't reach everywhere – that's a big problem for equitable COVID-19 vaccination

So far, the only COVID-19 vaccines authorized for use need to be kept frozen. But there are many places in the world that can't support a cold supply chain.

Charles M. Schweik, Professor of Environmental Conservation, University of Massachusetts Amherst • conversation
Jan. 4, 2021 ~7 min

public-health covid-19 coronavirus vaccines sars-cov-2 cdc cold-chain pfizer health-equity moderna centers-for-disease-control medical-ethics vaccine-distribution

/

71